Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Bardaweel SK, Hajjo R, Sabbah A
"We believe that if even a single patient feels the need to turn to potentially unsafe and unapproved knockoff alternatives, that's one too many." GoodRx replaces a now-defunct partnership between Novo Nordisk and Hims & Hers, which broke down due to what the drugmaker said were concerns about "illegal mass compounding and deceptive marketing." In a statement, GoodRx chief executive Wendy Barnes said that demand for GLP-1 drugs "is at an all-time high, but too many Americans still face barriers accessing them
Pharm Res 2007
Pricing reflects PlexusDx published rates as of April 2026
Medical Management and Plan Design Strategies To manage utilization and control costs, many employers are implementing structured medical management approaches rather than offering open access coverage
US$ 22.76
US$ 22.04
US$ 27.62
US$ 22.74
US$ 25.75
US$ 22.89
